A detailed history of Two Sigma Investments, LP transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 22,459 shares of ENOB stock, worth $103,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,459
Holding current value
$103,311
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
22,459 New
22,459 $103,000
Q2 2023

Aug 14, 2023

SELL
$0.4 - $1.3 $10,051 - $32,667
-25,129 Reduced 44.75%
31,023 $17,000
Q1 2023

May 15, 2023

SELL
$0.91 - $1.31 $30,498 - $43,904
-33,515 Reduced 37.38%
56,152 $51,000
Q4 2022

Feb 14, 2023

SELL
$1.03 - $2.13 $51,825 - $107,173
-50,316 Reduced 35.94%
89,667 $92,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $2.86 $82,810 - $139,316
-48,712 Reduced 25.82%
139,983 $253,000
Q2 2022

Aug 15, 2022

BUY
$1.93 - $8.73 $364,181 - $1.65 Million
188,695 New
188,695 $364,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.